Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase III, Clinical Trial to Assess the Long Term Safety and Tolerability of MK-0653C in Japanese Patients With Hypercholesterolemia Who Have Inadequate LDL-C Control on Ezetimibe or Atorvastatin Calcium Monotherapy

NCT02460159 is registered in ClinicalTrials.gov with Organon and Co as lead sponsor.

NCT NCT02460159
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02460159 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase III, Clinical Trial to Assess the Long Term Safety and Tolerability of MK-0653C in Japanese Patients With Hypercholesterolemia Who Have Inadequate LDL-C Control on Ezetimibe or Atorvastatin Calcium Monotherapy
Lead sponsor
Organon and Co
Phase
Phase 3
Overall status
Completed
Start date
June 23, 2015
Completion date
December 22, 2016
Enrollment
135 (actual)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

heterozygous familial hypercholesterolemia, hypercholesterolemia